Wellnex Life Ltd (ASX: WNX) Share Price and News

Price

$0.265

Movement

0.005 (+1.92%)

as at 23 May - Closed (20 mins delayed)

52 Week Range

$0.225 - $1.45

 
1 Year Return

-79.11%

Wellnex Life Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.50
$1.00
$0.00
$0.50
$1.00
$0.00
$0.50
$1.00
$0.00
$0.50
$1.00

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.96 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 67.77 million
Earnings per share -0.164
Dividend per share N/A
Year To Date Return -55.69%
Earnings Yield N/A
Franking -
Share Price

$0.265

Day Change

0.005 (+1.92%)

52 Week Range

$0.225 - $1.45

Yesterday's Close

$0.26

Today's Open

$0.26

Days Range

$0.245 - $0.265

Volume

78,259

Avg. Volume (1 month)

88,714

Turnover

$19,593

as at 23 May - Closed

Wellnex Life Ltd (ASX: WNX)
Latest News

a woman
Growth Shares

Are these ASX shares the next a2 Milk Company?

Could one of these small cap shares be the next A2 Milk Company Ltd (ASX:A2M)?

Read more »

a woman
Share Gainers

Why Afterpay, Praemium, Wattle Health, & WPP shares raced higher today

The Afterpay Touch Group Ltd (ASX:APT) share price and the Wattle Health Australia Ltd (ASX:WHA) share price have raced higher…

Read more »

a woman
Share Market News

Why the Wattle Health share price stormed higher today

The Wattle Health Australia Ltd (ASX:WHA) share price has stormed higher on Tuesday after returning from its trading halt. Here's…

Read more »

a woman
Share Market News

Wattle Health updates market on B&P acquisition

Shares in infant formula company Wattle Health Australia Limited (ASX: WHA) were flat in today’s trading session, following an update…

Read more »

a woman
Share Fallers

Bellamy's, a2 Milk, Bubs shares sink on China's new baby formula rules

The A2 Milk Company Ltd (ASX:A2M) share price is getting hammered.

Read more »

a woman
Share Fallers

Should you buy BWX and these beaten down ASX shares?

The BWX Ltd (ASX:BWX) share price has been hammered over the last 12 months. Is this a buying opportunity?

Read more »

a woman
Share Gainers

ALL ORDINARIES finishes higher Thursday: 8 shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Thursday.

Read more »

a woman
Share Gainers

Why FlexiGroup, Orica, Qantas, & Wattle Health shares surged higher today

The FlexiGroup Limited (ASX:FXL) share price and the Qantas Airways Limited (ASX:QAN) share price are two of four surging higher…

Read more »

a woman
Share Gainers

Why the Wattle Health share price stormed 13% higher today

The Wattle Health Australia Ltd (ASX:WHA) share price returned to trade today and stormed 13% higher. Here's why...

Read more »

a woman
Share Market News

Will the Bubs Australia share price fall after its acquisition?

The Bubs Australia Ltd (ASX: BUB) share price could fall lower in early trade after completing an acquisition and announcing…

Read more »

a woman
Share Market News

Bubs Australia share price on watch after selling non-core assets

The Bubs Australia Ltd (ASX: BUB) share price is in focus this morning after announcing the sale of non-core assets…

Read more »

a woman
Share Gainers

Why the Wattle Health share price is charging higher today

The Wattle Health Australia Ltd (ASX:WHA) share price has charged higher on Monday. Here's why...

Read more »

WNX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
20th May 2025 2025-05-20T08:23:04 Cleansing NoticeYesNo8:23am148k
20th May 2025 2025-05-20T08:22:54 Application for quotation of securities - WNXYesNo8:22am617k
13th May 2025 2025-05-13T09:18:04 Trading UpdateYesNo9:18am2170k
6th May 2025 2025-05-06T09:09:52 Final Director's Interest NoticeYesNo9:09am2134k
6th May 2025 2025-05-06T08:42:11 Board and Management ChangesYesNo8:42am2140k
14th Apr 2025 2025-04-14T17:12:00 Becoming a substantial holderYesNo5:12pm3153k
10th Apr 2025 2025-04-10T08:54:59 Appointment of Powermed Plus as UK DistributorYesNo8:54am2140k
8th Apr 2025 2025-04-08T09:49:06 Appendix 4C and Quarterly Report for Mar 2025 QuarterYesNo9:49am7381k
1st Apr 2025 2025-04-01T17:26:42 Ceasing to be a substantial holderYesNo5:26pm3155k
1st Apr 2025 2025-04-01T16:51:22 Change in substantial holdingYesNo4:51pm5867k

About Wellnex Life Ltd

Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes on production of dairy products focuses on infant formula and dried dairy goods. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.

WNX Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
23 May 2025 $0.27 $0.01 3.85% 78,259 $0.26 $0.27 $0.25
22 May 2025 $0.26 $0.01 3.92% 256,651 $0.25 $0.26 $0.23
21 May 2025 $0.26 $0.01 4.08% 5,640 $0.25 $0.26 $0.25
20 May 2025 $0.25 $-0.02 -7.69% 71,051 $0.27 $0.27 $0.25
19 May 2025 $0.26 $0.00 0.00% 64,825 $0.28 $0.28 $0.26
16 May 2025 $0.26 $-0.02 -7.14% 22,257 $0.28 $0.28 $0.26
15 May 2025 $0.28 $0.00 0.00% 68,799 $0.29 $0.29 $0.27
14 May 2025 $0.29 $0.02 7.41% 57,782 $0.26 $0.29 $0.26
13 May 2025 $0.27 $0.01 3.85% 131,288 $0.31 $0.31 $0.27
12 May 2025 $0.26 $-0.02 -7.14% 39,432 $0.28 $0.28 $0.26
09 May 2025 $0.28 $0.02 7.55% 14,662 $0.27 $0.28 $0.26
08 May 2025 $0.27 $-0.02 -7.02% 84,814 $0.28 $0.28 $0.26
07 May 2025 $0.29 $0.04 16.00% 99,992 $0.25 $0.29 $0.25
06 May 2025 $0.25 $-0.04 -13.79% 265,185 $0.29 $0.29 $0.24
05 May 2025 $0.29 $-0.01 -3.33% 35,398 $0.30 $0.30 $0.29
02 May 2025 $0.30 $-0.02 -6.25% 209,585 $0.32 $0.32 $0.29
01 May 2025 $0.32 $0.01 3.17% 121,957 $0.32 $0.32 $0.30
30 Apr 2025 $0.32 $-0.01 -3.08% 3,530 $0.32 $0.33 $0.32
29 Apr 2025 $0.33 $0.01 3.13% 160,592 $0.32 $0.33 $0.32
28 Apr 2025 $0.32 $-0.02 -5.88% 25,030 $0.33 $0.33 $0.32
24 Apr 2025 $0.34 $-0.03 -8.22% 21,915 $0.35 $0.35 $0.33

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
05 Mar 2025 George Karafotias Issued 68,064 $44,242
Rights issue.
05 Mar 2025 Zlatko (Zack) Bozinovski Issued 184,615 $120,000
Rights issue.
05 Mar 2025 Jeffrey Yeh Issued 1,999,999 $1,300,000
Rights issue.
07 Feb 2025 Jeffrey Yeh Issued 871,429 $697,143
Issue of securities. Deemed Issue
23 Dec 2024 Jeffrey Yeh Issued 200,000 $280,000
Issue of securities. No cash consideration
Deemed Issue
17 Oct 2024 George Karafotias Buy 5,000 $4,420
On-market trade. .
16 Sep 2024 Zlatko (Zack) Bozinovski Buy 1,190,593 $25,002
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Eric Jiang Non-Executive Director Sep 2016
Mr Jiang has over 15 years' experience and is an adviser to companies involved in trade between Australia and China. Eric brings understanding of the cultural, economic and strategic context in which Australian businesses engage with China.
Mr George Karafotias Chief Financial OfficerExecutive Director Nov 2020
Mr Karafotias has held roles in public companies over the last 9 years and has previously provided corporate advisory services to listed and unlisted companies, focusing on restructuring and refinancing.
Mr Zlatko (Zack) Bozinovski Chief Strategy OfficerExecutive Director Jul 2021
Mr Bozinovski is executive in the Australian retail industry with over 35 years' experience within FMCG and Pharmaceuticals companies in Australia and internationally. Mr Bozinovski co-founded Voost and has previously held senior positions at Uncle Tobys/Goodman Fielder, Pepsi Co and Sigma Pharmaceuticals.
Mr Andrew Vidler Non-Executive Director Jan 2024
Mr Vidler has experience across retail, consumer health products and retail pharmacy. Andrew in his over 30 years' experience includes nearly 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where across roles he led the Terry White and Chemmart pharmacy brands and the Endeavour consumer health products business.
Mr Jeffrey Yeh Non-Executive Director Jan 2024
Mr Yeh is an experienced all-rounded entrepreneur, with over 21 years' experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management.
Mr Ruari McGirr Non-Executive Director Mar 2025
--
Mr Yuan (Vivenne) Zhang Non-Executive Director Mar 2025
--
Mr Zheng (Kobe) Li Company Secretary Jan 2019
-
Zheng (Kobe) Li Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Homart Group Pty Ltd 83,508,573 5.96%
Kobella Holdings Pty Ltd (The Kobella Holding Unit A/C) 68,571,428 4.89%
Jysf Management Pty Ltd (Jysf A/C) 65,729,522 4.69%
Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) 40,154,760 2.86%
Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) 32,732,760 2.33%
Citicorp Nominees Pty Limited 32,661,975 2.33%
Gleneagle Securities Nominees Pty Limited 32,142,855 2.29%
HSBC Custody Nominees (Australia) Limited 30,559,496 2.18%
Morrison Securities Pty Ltd (Placements A/C) 28,836,995 2.06%
Zjl Pty Ltd (The Bozinovski Family A/C) 24,142,857 1.72%
18120 Pty Ltd (Hmej A/C) 22,657,143 1.62%
Lotus Capital Group Pty Ltd 19,882,100 1.42%
Gleneagle Securities (Aust) Pty Ltd 19,700,000 1.41%
Pear Management Pty Ltd 19,603,863 1.40%
Reid Jon Zulpo (Rj & Mc Zulpo Family A/C) 19,021,740 1.36%
Cw Retail Holdings Pty Ltd (Cw Retail Holdings A/C) 18,869,792 1.35%
Wattle Trading Pty Ltd 18,831,453 1.34%
Onslow Management Services Pty Ltd Ltd (Esperance A/C) 17,857,143 1.27%
Monex Boom Securities (Hk) Ltd (Clients Account) 17,750,302 1.27%
Mrs Jieni Jeffrey 16,669,265 1.19%

Profile

since

Note